uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies

Urokinase plasminogen activator (uPA) is an extracellular matrix-degrading protease involved in cancer invasion and metastasis, interacting with plasminogen activator inhibitor-1 (PAI-1), which was originally identified as a blood-derived endogenous fast-acting inhibitor of uPA. At concentrations fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Duffy, Michael J, McGowan, Patricia M, Harbeck, Nadia, Thomssen, Christoph, Schmitt, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423643/
https://www.ncbi.nlm.nih.gov/pubmed/25677449
http://dx.doi.org/10.1186/s13058-014-0428-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423643/
https://www.ncbi.nlm.nih.gov/pubmed/25677449
http://dx.doi.org/10.1186/s13058-014-0428-4

Ejemplares similares